CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes

被引:0
|
作者
Xiao-ping ZHAO Jiao ZHONG Xiao-quan LIU~2 Guang-ji WANG Key Laboratory of Drug Metabolism and Pharmacokinetics
机构
关键词
vinflunine; metabolism; CYP3A4; liver microsomes;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Aim:To study the metabolism of vinflunine and the effects of selective cyto-chrome P-450(CYP450)inhibitors on the metabolism of vinflunine in human livermicrosomes.Methods:Individual selective CYP450 inhibitors were used to inves-tigate their effects on the metabolism of vinflunine and the principal CYP450 isoforminvolved in the formation of metabolites M1and M2in human liver microsomes.Results:Vinflunine was rapidly metabolized to 2 metabolites:M1and M2in humanliver microsomes.M1and M2were tentatively presumed to be the N-oxide metabo-lite or hydroxylated metabolite and epoxide metabolite of vinflunine,respectively.Ketoconazole uncompetitively inhibited the formation of M1,and competitivelyinhibited the formation of M2,while α-naphthoflavone,sulfaphenazole,diethyldithiocarbamate,tranylcypromine and quinidine bad little or no inhibitory effecton the formation of M1and M2.Conclusion:Vinflunine is rapidly metabolized inhuman liver microsomes,and CYP3A4 is the major human CYP450 involved in themetabolism of vinflunine.
引用
收藏
页码:118 / 124
页数:7
相关论文
共 50 条
  • [41] Development of Mice Exhibiting Hepatic Microsomal Activity of Human CYP3A4 Comparable to That in Human Liver Microsomes by Intravenous Administration of an Adenovirus Vector Expressing Human CYP3A4
    Kuno, Shuichi
    Sakurai, Fuminori
    Shimizu, Kahori
    Matsumura, Naoya
    Kim, Soonih
    Watanabe, Hitoshi
    Tashiro, Katsuhisa
    Tachibana, Masashi
    Yokoi, Tsuyoshi
    Mizuguchi, Hiroyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (04) : 296 - 304
  • [42] Estimation of the Contribution of CYP2C8 and CYP3A4 in Repaglinide Metabolism by Human Liver Microsomes Under Various Buffer Conditions
    Kudo, Toshiyuki
    Goda, Hitomi
    Yokosuka, Yuki
    Tanaka, Ryo
    Komatsu, Seina
    Ito, Kiyomi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2847 - 2852
  • [43] Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro
    Xie, Sai-li
    Zhu, Xiayan
    Gao, Nanyong
    Lin, Qianmeng
    Chen, Chaojie
    Yang, Yun-jun
    Cai, Jian-ping
    Hu, Guo-xin
    Xu, Ren-ai
    FOOD AND CHEMICAL TOXICOLOGY, 2023, 181
  • [44] In-Vitro CYP3A4, CYP2E1 and UGT Activity in Human Liver Microsomes by Strobilanthes crispus Leaf Extracts
    Akowuah, Gabriel Akyirem
    Chin, Jin Han
    Yeong, Siew Wei
    Quah, Suk Yen
    Ahmad, Mariam
    NATURAL PRODUCTS JOURNAL, 2020, 10 (02): : 104 - 112
  • [45] Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes
    Granvil, CP
    Madan, A
    Sharkawi, M
    Parkinson, A
    Wainer, IW
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (04) : 533 - 541
  • [46] Effects of CYP3A4 Variants on Methadone Metabolism In Vitro
    Wang, Chen-chen
    Zhang, Ming-lei
    Xu, Yan-dan
    Hu, Guo-xin
    Cai, Jian-ping
    Lan, Tian
    Bai, Yong-feng
    BIOMEDICAL CHROMATOGRAPHY, 2025, 39 (01)
  • [47] Assessment of CYP3A4(3A4) contribution to bupropion (B) hydroxylation in human liver microsomes (HLMs).
    Faucette, S
    Hawke, R
    Shifflett, S
    LeCluyse, E
    Lindley, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 99 - 99
  • [48] Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes
    Tang, Lan
    Ye, Ling
    Lv, Chang
    Zheng, Zhijie
    Gong, Yun
    Liu, Zhongqiu
    TOXICOLOGY LETTERS, 2011, 202 (01) : 47 - 54
  • [49] Prediction of In Vivo Interaction Between Triazolam and Erythromycin Based on In Vitro Studies Using Human Liver Microsomes and Recombinant Human CYP3A4
    Shin-ichi Kanamitsu
    Kiyomi Ito
    Carol E. Green
    Charles A. Tyson
    Noriaki Shimada
    Yuichi Sugiyama
    Pharmaceutical Research, 2000, 17 : 419 - 426
  • [50] Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4
    Kanamitsu, S
    Ito, K
    Green, CE
    Tyson, CA
    Shimada, N
    Sugiyama, Y
    PHARMACEUTICAL RESEARCH, 2000, 17 (04) : 419 - 426